- m
Global Biosimilars Market Size & Trends Report Segmented by Product (mAbs,...
- meditechinsights.com
Updated Jul 11, 2025
Share
Facebook
Twitter
EmailClick to copy linkLink copiedCiteMedi-Tech Insights - Medi-Tech (2025). Global Biosimilars Market Size & Trends Report Segmented by Product (mAbs, Insulin, G-CSF, Erythropoietin, hGH, Interferons), Application (Oncology, Autoimmune, Diabetes, Blood Disorders, Infectious Diseases), Manufacturing Type (In-house, Contract) Forecast to 2030 [Dataset]. https://meditechinsights.com/global-biosimilars-market/Dataset updatedJul 11, 2025Dataset authored and provided byMedi-Tech Insights - Medi-TechLicensehttps://meditechinsights.com/privacy-policy/https://meditechinsights.com/privacy-policy/
DescriptionThe global biosimilars market is set to witness a CAGR of ~15% in the next 5 years. Impending patent expiry of blockbuster biologics, cost containment strategies by governments and payers, rising demand for affordable alternatives for costly biologics, strong regulatory support and clear guidelines, and increased physician and patient acceptance are some of the key […]
- m
Biosimilars Market Size, Trends, Growth & Share Analysis 2025 - 2030
- mordorintelligence.com
pdf,excel,csv,pptUpdated Jul 2, 2025ShareFacebookTwitterEmailClick to copy linkLink copiedCiteMordor Intelligence (2025). Biosimilars Market Size, Trends, Growth & Share Analysis 2025 - 2030 [Dataset]. https://www.mordorintelligence.com/industry-reports/global-biosimilars-market-industrypdf,excel,csv,pptAvailable download formatsDataset updatedJul 2, 2025Dataset authored and provided byMordor IntelligenceLicensehttps://www.mordorintelligence.com/privacy-policyhttps://www.mordorintelligence.com/privacy-policy
Time period covered2019 - 2030Area coveredGlobalDescriptionThe Biosimilars Market Report Segments the Industry Into by Product Class (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-Inflammatory Agents, Other Product Classes), by Application (Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).
Not seeing a result you expected?
Learn how you can add new datasets to our index.
FacebookTwitterEmailGlobal Biosimilars Market Size & Trends Report Segmented by Product (mAbs, Insulin, G-CSF, Erythropoietin, hGH, Interferons), Application (Oncology, Autoimmune, Diabetes, Blood Disorders, Infectious Diseases), Manufacturing Type (In-house, Contract) Forecast to 2030
https://meditechinsights.com/privacy-policy/https://meditechinsights.com/privacy-policy/
The global biosimilars market is set to witness a CAGR of ~15% in the next 5 years. Impending patent expiry of blockbuster biologics, cost containment strategies by governments and payers, rising demand for affordable alternatives for costly biologics, strong regulatory support and clear guidelines, and increased physician and patient acceptance are some of the key […]